MicroRNA and messengerRNA expression changes during interferon-beta and glatiramer acetate treatment in peripheral blood cells of multiple sclerosis patients
Thamilarasan, Madhan
1981-
aut
text
theses
Text
Hochschulschrift
gw
2014
monographic
XA-DE
2014
eng
text/html
application/pdf
Online-Ressource Ill., graph. Darst.
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system. There are many types of disease-modifying drugs available but none of them can cure MS. The studies reported in this thesis analyzed the changes which happen at the transcriptome level during the course of treatment with glatiramer acetate (GA) and interferon-beta-1b. The studies reported revealed several differentially expressed transcripts which included both mRNAs and microRNAs. These can be considered as biomarkers for therapy monitoring and help to better understand the mechanisms of action of the drugs.
Madhan Thamilarasan
Enth. 4 Beitr. aus versch. Ztschr
Rostock, Univ., Med. Fak., Diss., 2015
610
44.90
42.13
http://rosdok.uni-rostock.de/resolve?urn=urn:nbn:de:gbv:28-diss2015-0098-2
http://rosdok.uni-rostock.de/resolve?urn=urn:nbn:de:gbv:28-diss2015-0098-2&pdf
http://nbn-resolving.de/urn:nbn:de:gbv:28-diss2015-0098-2
MicroRNA and messengerRNA expression changes during interferon-beta and glatiramer acetate treatment in peripheral blood cells of multiple sclerosis patients
2014
(DE-627)821498789
Thamilarasan, Madhan, 1981 -
urn:nbn:de:gbv:28-diss2015-0098-2
935871467
rakwb
DE-627
150610
827024207
20230428T195049.0
Converted from MARCXML to MODS version 3.8 using MARC21slim2MODS3-8_XSLT1-0.xsl
(Revision 1.174 20250328)
ger